Overview

Detailed Summary

Procter & Gamble Hygiene and Health Care Limited manufactures and sells fast-moving consumer goods, focusing on feminine and healthcare products. Their portfolio includes phenomenally popular brands like Whisper in feminine care and Vicks in health care.
In FY 2024-25, P&G achieved balanced growth, with strong top- and bottom-line performance despite a shortened 9-month fiscal year.
The company has integrated advanced AI/ML technologies for supply chain optimizations to enhance store-specific product assortments and improve retail execution efficiency.
P&G made significant productivity savings amounting to INR 93 crores in FY 24/25 through efficiency improvements and resource optimization.
The company prioritizes social impact, exemplified by their initiatives impacting over 50 lakh students, which underscore their commitment to community engagement and social responsibility.

Sector: Personal Products
Industry: Personal Care
Market Cap: 28,695 Cr
Volatility: Low Risk
P/E Ratio: 33.5
Industry P/E: 45.2
PEG Ratio: 5.0
P/B Ratio: 38.2
52W High: 14,536.60
52W Low: 8,739.70

Sales CAGR

1Y: -19.77%
3Y: —
5Y: —
10Y: —

Profit CAGR

1Y: -5.69%
3Y: —
5Y: —
10Y: —

ROE

TTM: 113.67%
3Y: 86.38%
5Y: 86.38%
10Y: 86.38%

ROCE

TTM: 155.91%
3Y: 102.67%
5Y: 102.67%
10Y: 102.67%

Technicals

‌

Forecasts

Unlock more with professional

Analyst Target, Price, EPS and Revenue Projections
Get In-depth insights on EPS and Revenue forecasts

Peers

Fast Moving Consumer Goods Fast Moving Consumer Goods Personal Products Personal Care

Symbol	Watchlist	Price	Market Cap	P/E	P/B	Div Yield (%)	ROE (%)	ROCE (%)	ROA (%)
COLPAL		2008.25	54,622 Cr	41.21	34.48	2.89	83.66	109.56	38.89
CUPID		216.85	29,159 Cr	269.42	64.68	0.00	24.01	28.64	19.56
PGHH		8870.40	28,794 Cr	33.62	38.22	2.87	113.67	155.91	47.49
GILLETTE		7820.25	25,499 Cr	38.97	26.94	0.77	69.13	94.29	34.96
EMAMILTD		419.00	18,337 Cr	23.65	6.27	1.43	26.51	27.65	20.21
HONASA		475.00	15,486 Cr	77.45	10.96	0.63	14.16	17.48	9.57
BAJAJCON		591.00	7,720 Cr	34.61	10.22	0.00	25.24	30.28	23.60
Median: 7 Co.	—	591.00	25,499 Cr	38.97	26.94	0.77	26.51	30.28	23.60

Financial Statements

Upcoming Result Date: Jul 28, 2026

AI Powered Summary

Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.

Ask AI

Standalone Quarterly Results (in ₹ Crores)

Total Figures

QoQ Changes

Total Figures

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales	1,133	1,002	932	1,135	1,248	992	937	1,150	1,262	941
Expenses	824	745	813	845	877	782	671	865	860	723
Operating Profit	310	257	118	290	371	210	266	285	402	218
OPM %	27.33	25.68	12.70	25.59	29.73	21.14	28.41	24.76	31.84	23.19
Other Income	16	14	7.31	8.50	9.71	19	7.69	9.90	12	12
Interest	2.55	22	-0.03	1.91	6.62	5.77	0.07	3.60	2.67	3.11
Depreciation	14	15	13	12	9.89	10	9.09	9.28	9.50	9.56
Profit Before Tax	309	234	112	285	364	213	265	282	402	218
Tax %	25.80	34.01	27.81	25.75	26.24	26.60	27.44	25.52	25.02	29.79
Net Profit	229	154	81	212	269	156	192	210	301	153
EPS in Rs	70.51	47.56	24.97	65.28	82.74	48.09	59.17	64.65	92.87	47.17

Standalone Profit Loss (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Mar 2025	Mar 2026
Sales	2,419	2,455	2,947	3,002	3,574	3,901	3,918	4,206	3,374	4,311
Expenses	1,656	1,840	2,338	2,398	2,690	3,071	3,049	3,235	2,503	3,174
Operating Profit	763	615	609	604	884	830	869	970	871	1,137
OPM %	31.56	25.06	20.67	20.11	24.74	21.27	22.17	23.07	25.81	26.38
Other Income	77	24	53	44	39	24	41	52	37	45
Interest	10	5.32	5.48	6.07	6.11	11	11	27	14	14
Depreciation	60	52	50	48	48	53	58	57	32	41
Profit Before Tax	672	582	607	594	870	790	839	939	862	1,127
Tax %	35.58	35.61	30.99	27.07	25.07	27.13	19.22	28.13	26.16	26.46
Net Profit	433	375	419	433	652	576	678	675	637	829
EPS in Rs	—	—	—	—	—	—	—	—	221.08	263.86
Dividend Payout %	291.80	34.66	68.15	78.70	156.88	90.21	88.55	122.63	89.24	—

Standalone Balance Sheet (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Mar 2025
Equity Capital	32	32	32	32	32	32	32	32	32	32
Reserves	1,619	494	773	877	1,125	682	705	914	742	705
Borrowings	0.00	0.00	0.00	0.00	0.00	3.47	5.10	4.03	3.08	2.32
Other Liabilities	515	634	620	708	671	915	940	1,187	1,081	1,015
Total Liabilities	2,166	1,160	1,425	1,617	1,828	1,633	1,683	2,137	1,859	1,755
Fixed Assets	317	286	250	234	207	184	164	170	139	131
CWIP	35	41	21	15	22	38	44	23	28	41
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	1,814	834	1,154	1,368	1,600	1,411	1,475	1,945	1,692	1,583
Total Assets	2,166	1,160	1,425	1,617	1,828	1,633	1,683	2,137	1,859	1,755

Standalone Cash Flows (in ₹ Crores)

Total Figures

YoY Changes

Total Figures

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Mar 2025
Cash from Operating Activity	352	445	415	413	474	863	573	826	471	593
Cash from Investing Activity	221	149	-19	34	75	6.94	-27	-9.91	1.06	-34
Cash from Financing Activity	-122	-1,559	-106	-314	-190	-1,106	-569	-477	-862	-666
Net Cash Flow	452	-964	290	134	358	-236	-23	339	-390	-107

Shareholdings

Shareholding History

Quarterly

Yearly

Quarterly

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoters	70.64%	70.64%	70.64%	70.64%	70.64%	70.64%	70.64%	70.64%	70.64%	70.64%	70.64%	70.64%
FIIs	1.13%	1.30%	1.48%	1.57%	1.56%	1.48%	1.43%	1.33%	1.38%	1.11%	1.07%	0.97%
DIIs	15.49%	15.44%	15.29%	15.11%	15.16%	15.28%	15.37%	15.51%	15.49%	16.05%	16.04%	15.97%
Public	12.74%	12.62%	12.59%	12.68%	12.65%	12.60%	12.56%	12.52%	12.48%	12.19%	12.26%	12.43%
Total Shareholders	39,388	37,069	38,807	39,999	40,671	42,348	42,941	44,877	47,891	49,997	50,969	53,416

Market Transactions

Unlock more with professional

Real-time bulk & block deal transactions
Export transaction data for analysis

Projection

Unlock more with professional

Analyst Target, Price, EPS and Revenue Projections
Get In-depth insights on EPS and Revenue forecasts

Documents

Presentations

Concalls

Reports

Presentations

Investor Presentation

Q4 FY25

Investor Presentation

Q1 FY25

Investor Presentation

Q1 FY24

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

Investor Presentation

Q3 FY19

Available on Pro Plan

Unlock reports, presentations, and AI-powered insights.

Actions

Action Type

‌
‌

Announcements

Last 7 days

Newest

Sentiment

AGM/EGM Notice

4 days ago

P&G Hygiene & Health Care AGM Sep 2 2026

Procter & Gamble Hygiene and Health Care Ltd informs exchanges its 62nd AGM will be held on 2026-09-02; record date is 2026-08-26; dividend, if approved at the AGM, will be paid by 2026-09-30.

AGM/EGM Notice

4 days ago

Procter & Gamble HHCL: Record Date for AGM & Dividend

Procter & Gamble Hygiene and Health Care Ltd updates AGM schedule: AGM on 2026-09-02; Record Date for AGM and payment of dividend (if approved) is 2026-08-26; dividend to be paid by 2026-09-30.

AI Mode

Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.

Ask AI

Frequently Asked Questions about Procter & Gamble Hygiene and Health Care Ltd

Procter & Gamble Hygiene and Health Care Ltd (PGHH) is currently trading at 8,840.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Procter & Gamble Hygiene and Health Care Limited manufactures and sells fast-moving consumer goods, focusing on feminine and healthcare products. Their portfolio includes phenomenally popular brands like Whisper in feminine care and Vicks in health care. In FY 2024-25, P&G achieved balanced growth, with strong top- and bottom-line performance despite a shortened 9-month fiscal year. The company has integrated advanced AI/ML technologies for supply chain optimizations to enhance store-specific product assortments and improve retail execution efficiency. P&G made significant productivity savings amounting to INR 93 crores in FY 24/25 through efficiency improvements and resource optimization. The company prioritizes social impact, exemplified by their initiatives impacting over 50 lakh students, which underscore their commitment to community engagement and social responsibility.

Over the past 52 weeks, Procter & Gamble Hygiene and Health Care Ltd has traded between a low of ₹8,739.70 and a high of ₹14,536.60. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Procter & Gamble Hygiene and Health Care Ltd has a market capitalization of approximately 28,793.97. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Procter & Gamble Hygiene and Health Care Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 33.62 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 28,793.97 Cr, Procter & Gamble Hygiene and Health Care Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Procter & Gamble Hygiene and Health Care Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Procter & Gamble Hygiene and Health Care Ltd is 33.62. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

The budget proposes setting up 'SHE marts' for rural women-led enterprises. This creates a new, targeted retail channel that PGHH can leverage to increase the distribution and sales of its products, especially feminine hygiene brand Whisper, in rural markets.

Procter Gamble Hygiene And Health Care Ltd

Stock Summary and Key Metrics

Investment Checklist

Investment Checklist

Overview

Financial Ratios

Technicals

Forecasts

Unlock more with professional

Peers

Price Chart Comparison